NCT03680586View on ClinicalTrials.gov

Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
Interventions
DRUG

Radiation Therapy

Undergo ultra low-dose radiation

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER